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The Hazards of Rubella Serodiagnosis
from Single Serum Studies in Pregnancy

Gerald A. LoGrippo, M.D.* and Hajime Hayashi, Ph.D.*

Hemagglutination-inhibition
(HA-I) titres for rubella were studied in 200 nurses,
87 pregnant women, in plasma and serum pools, and in laboratory personnel. The
percentage of individuals susceptible to rubella in the child-bearing ages was 11.5%>
among the non-pregnant nurses and 23% among the pregnant women assayed at
their first prenatal visit. Serodiagnosis of active rubella necessitates two or more
serial serum studies during the first trimester of pregnancy.

The hazards of maternal rubella and
congenital malformation of the neonate
is well established.!- Serodiagnosis
from hemagglutination-inhibition (HAI) test on single specimens offer limited information on the immunologic
status of the pregnant women. At best,
the single serum H A - I test differentiates only that an individual "does" or
"does not" possess H A - I antibodies.
Unless complementary studies are conducted during pre-natal care, single
H A - I titres do not reflect the immunologic status of the host in relation to:
(1) primary active, natural infection;
(2) recrudescence of indigenous rubella

from an upper respiratory carrier
state;- and (3) relation of H A - I titre to
the immunologic competence of the
mother to protect her fetus from viremia during all of these episodes.
This report presents the rubella data
accumulated over the years and emphasizes the difference between serodiagnostic values in relation to immunologic responses.
Materials and Methods
Hemagglutination-inhibition (HA -I)
Assays. The H A - I test for rubella used
in this laboratory is that described by
Stewart et al.=* Quality control for consistently reproducible results has been
a laboratory problem when virus anti-
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Single Serum Reports
a) Negative immune response
b) Questionable immune response
c) Positive immune response

Ranges of HA-I Titre
1:4 or less
1:8 and 1:16
1:32 or greater
stools and upper respiratory excretions.
Serum assays for HA-I titres were also
studied in (a) 12 healthy laboratory
personnel; (b) 13 lots of plasma pools
(100 to 200 donors per pool) available
from the plasma sterilization program ;''•* and (c) 16 lots of serum pools
(800-1000 donors per pool) from the
hospital serology laboratory. The plasma pools represent a supposedly
healthy population studied from 19601967. The serum pools represent an ill
population of hospital admissions
studied from 1967 to 1970. All sera except serum pools were collected prior
to the availability of rubella liVe vaccine.
Results
Rubella Antibody Titres: Table I
compares the HA-I antibody titres
found in these groups. Eighteen of 200
nurses (9%) showed negative immune
responses (HA-I titre ^ 1:4); 5 of 200
(2.5%) showed questionable immune
responses (1:8 and 1:16 titres); and
177 of 200 (88.5%) showed positive
immune responses ( ^ 1:32 titres). All
of the laboratory personnel, plasma
pools and serum pools demonstrated
positive immune responses except for
one laboratory technician with a questionable immune response (1:16 titre).
The plasma pools and serum pools
showed the median HA-I titres (1:128
to 1:256) representing an expectancy
range in the general population. The
same median titres were seen in the
individual assays as those found in the

gen and one-day-old chick erythrocytes
are supplied from commercial sources.
The criteria for antibody responses
to rubella for this laboratory are shown
above.
Serodiagnosis for active rubella infection necessitates simultaneous testing with paired sera (acute and convalescent) to demonstrate a 4-fold (2 dilutions) or greater increase in antibody
titre.
Immunoglobulin Determinations: The
major immunoglobulins (IgG, IgA and
IgM) are quantitated by a micro-double
diffusion in agar technic developed and
standardized in this laboratory.*'^*
Normal adult levels for immunoglobulins in serum (means ± 2 standard
deviations) used in this hospital are:
600-1400 mg/100 ml for IgG; 30-135
mg/100 ml for IgA; and 30-120 mg/
100 ml for IgM.
Sera Studied: Sera from 87 pregnant
women were assayed for rubella HA-I
titres and major immunoglobulin
values (IgG, IgA and IgM) on the first
and subsequent prenatal visits to the
Department of Obstetrics during 1967
to 1969. Sera on 200 Henry Ford Hospital nurses (ages 18 to 40 years) were
assayed by HA-I test to determine the
percentage of nonimmune personnel in
the child bearing ages during the same
period. There was a practical concern
about the hazards to the nurses rotating through pediatric service when it
was known that rubella-infected infants
were shedding live virus in the urine.
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TABLE I
HEMAGGLUTINATION INHIBITION (HA-I) TITRES TO RUBELLA VIRUS
AMONG H.F.H. POPULATION
Group
Total
u

Nurses

200

No. of Samples in Respective HA-I Titre Group
8
16 32 64 128 256 512
±4
18

j

1

4 1 5
1

M

14

39

51

21024

32

36

4

1

\

03

(9%)

a.

ro
a>
OT

=

Laboratory
Personnel

12

Plasma
pool*

13

Serum
pool**

16

Pregnant
Group
(1st Visit)

87

(2.5%)
1

10

4

6

(11.5%) ' (11.5%)

(88.5%)
1

1

2

2

3

5

5

3

6

5

2

15

14

10

11

1 7 10

(77%)

Bi-annual Blood Bank plasma pools since 1960 to 1967 (100 to 200 donors per pool).
Quarterly serum pools from Serology Laboratory from 1967 to 1970 ( 800-1000
individuals per pool).
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(4.8%). In our opinion, these deficiencies warrant complementary studies of immunologic competence in
qualitative responses to antigenic
stimuli. The correlation of these two
factors is under current investigation.

yearly pools from two different populations. Of 87 pregnant women, 10
(11.5%) showed negative immune responses, 10 (11.5%) questionable responses and 67 (77%) positive responses. The percentage of immune
responses in pregnant women closely
parallel those found among the nonpregnant nursing population, except for
the higher percentage in the questionable immune group.
Serum Immunoglobulin Levels in
Pregnancy: Table I I shows the serum
immunoglobulin status for 87 pregnant
women studied during the first prenatal visit. The serum immunoglobulin
levels are grouped under those within
normal ranges, those with immunoglobulin excesses and those with deficiencies. The largest percentage had normal or excess quantities of the three
immunoglobulins studied. But there
were considerable variations in immunoglobulin deficiencies as follows:
IgG (16.2%), IgM (2.9%) and IgA

Discussion
The literature quotes that 15% to
20% of women in the child bearing
age are susceptible to active rubella infections and have a high risk of bearing children with congenital malformation.^ i " The data in our study show
that 23% of the pregnant women and
11.5% of the non-pregnant nurses
with single serum specimen H A - I titres
equal to or less than 1:16 comprise this
risk group. The question arises what
serodiagnostic titre represents predictable levels of the mother's immunologic competence to protect the fetus
against transplacental infection. Lennette et a l " have demonstrated that
HA-I titres from 1:8 to 1:256 in acute

TABLE
SERUM IMMUNOGLOBULIN (Ig) STATUS IN 87 PREGNANT WOMEN
(FIRST PRENATAL VISITS)
Immunoglobulin
Levels

Percent of individuals in each group
IgG

IgM

IgA

Normal

73.3

66.6

82.9

Excesses

10.5

30.5

12.4

Deficiencies

16.2

2.9

4.8
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phase sera convert to 4-fold or greater
increases. Therefore, any H A - I titre
from 1:8 or greater in a single serum
study does not insure that the woman
is immune and not suffering a recurrent
infection. H A - I titres ranging from 1:8
to 2 56 may be a lower titre of a rising antibody response to active, current rubella infection. For this reason,
a single serum study is not satisfactory.
Moreover, a pregnant woman with a
positive HA-I titre cannot be assumed
to be immune with these titres, nor that
she has immunologic competence to
protect her fetus. Furthermore, a single
serum HA-I positive titre may be due
to reinfection even though the individual has been immunized.- In this regard, Lennette's data" and our own
unpublished studies strongly suggest
that complement fixing (CF) as well as
HA-I antibody assays be conducted to
differentiate varying phases of rubella
infection. CF and H A - I antibody studies should be performed in serial
serum specimens during the first trimester of pregnancy, preferably on a
monthly basis in all women.
Another factor to be considered in
a woman's humoral immune competence during pregnancy is her immunoglobulin status. Our data indicates

that the degrees and variations in
serum immunoglobulins play a major
role in the ability to respond adequately
to primary or recurrent rubella infections and to maintain residual antibody
levels. The quantitations of serum immunoglobulins is suggested in addition
to rubella serologic tests for a more
complete evaluation of the immunologic competence of pregnant women
who have histories of unusually frequent infections, especially if associated with serious complications.
In our opinion, all acute respiratory
infection in pregnant women during
the first trimester of pregnancy should
be considered rubella infection until
proven otherwise by serial serologic
studies. Serodiagnosis of rubella, with
or without a rash, can be made on the
sequence of sero-conversion of CF and
H A - I levels during the acute infection,
recovery stage (2-3 weeks later) and
convalescent stage (4-6 weeks after the
acute stage).
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